[go: up one dir, main page]

MY8700793A - 9-(1,3-dihydroxy-2-propoxymethyl)-guanine as anti viral agent - Google Patents

9-(1,3-dihydroxy-2-propoxymethyl)-guanine as anti viral agent

Info

Publication number
MY8700793A
MY8700793A MY793/87A MY8700793A MY8700793A MY 8700793 A MY8700793 A MY 8700793A MY 793/87 A MY793/87 A MY 793/87A MY 8700793 A MY8700793 A MY 8700793A MY 8700793 A MY8700793 A MY 8700793A
Authority
MY
Malaysia
Prior art keywords
propoxymethyl
guanine
dihydroxy
viral agent
anti viral
Prior art date
Application number
MY793/87A
Other languages
English (en)
Inventor
Julian P Verheyden
John C Martin
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23017790&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MY8700793(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of MY8700793A publication Critical patent/MY8700793A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
MY793/87A 1981-05-21 1987-12-30 9-(1,3-dihydroxy-2-propoxymethyl)-guanine as anti viral agent MY8700793A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06267210 US4355032B2 (en) 1981-05-21 1981-05-21 9-(1,3-dihydroxy-2-propoxymethyl)guanine as antiviral agent

Publications (1)

Publication Number Publication Date
MY8700793A true MY8700793A (en) 1987-12-31

Family

ID=23017790

Family Applications (1)

Application Number Title Priority Date Filing Date
MY793/87A MY8700793A (en) 1981-05-21 1987-12-30 9-(1,3-dihydroxy-2-propoxymethyl)-guanine as anti viral agent

Country Status (33)

Country Link
US (1) US4355032B2 (fr)
EP (1) EP0066208B1 (fr)
JP (2) JPS57203086A (fr)
KR (1) KR890004663B1 (fr)
AR (1) AR244227A1 (fr)
AT (1) ATE15899T1 (fr)
AU (1) AU572086B2 (fr)
BR (1) BR8202931A (fr)
CA (3) CA1305141C (fr)
CS (4) CS235042B2 (fr)
DD (2) DD203052A5 (fr)
DE (1) DE3266644D1 (fr)
DK (2) DK150304C (fr)
ES (7) ES512414A0 (fr)
FI (1) FI73682C (fr)
GR (1) GR76459B (fr)
HK (1) HK67088A (fr)
HU (2) HU188000B (fr)
IE (1) IE53731B1 (fr)
IL (1) IL65836A (fr)
IN (1) IN156469B (fr)
LU (1) LU88334I2 (fr)
MY (1) MY8700793A (fr)
NL (2) NL930022I1 (fr)
NO (2) NO161740C (fr)
NZ (1) NZ200691A (fr)
PH (1) PH17975A (fr)
PL (4) PL136637B1 (fr)
PT (1) PT74934B (fr)
RO (2) RO87387B (fr)
SG (1) SG81687G (fr)
SU (1) SU1176841A3 (fr)
ZA (1) ZA823532B (fr)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4508898A (en) * 1980-09-16 1985-04-02 Ogilvie Kelvin K Antiviral triazine compounds
US4347360A (en) * 1980-09-16 1982-08-31 Ens Bio Logicals Inc. Ring open nucleoside analogues
US5157120A (en) * 1980-09-16 1992-10-20 Syntex (U.S.A.) Inc. Guanine derivatives
US4507305A (en) * 1981-05-21 1985-03-26 Syntex (U.S.A.) Inc. 9-(1,3-Dihydroxy-2-propoxymethyl)guanine as antiviral agent
US4423050A (en) * 1981-05-21 1983-12-27 Syntex (U.S.A.) Inc. 9-(1,3-Dihydroxy-2-propoxymethyl)guanine as antiviral agent
IE54148B1 (en) * 1981-08-11 1989-07-05 Wellcome Found Antiviral compounds
NZ201662A (en) * 1981-08-26 1986-07-11 Merck & Co Inc 9-(1,3-(and 2,3)-dihydroxy-1-(and 2)-propoxy-methyl)guanine derivatives and methods for their preparation
IE830186L (en) * 1982-02-01 1983-08-01 Syntex Inc Purines
US5250535A (en) * 1982-02-01 1993-10-05 Syntex Inc. Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) purines as antiviral agent
US4902678A (en) * 1982-02-12 1990-02-20 Syntex (U.S.A.) Inc. Anti-viral compositions
US4609662A (en) * 1982-10-14 1986-09-02 Burroughs Wellcome Co. Method for using purine derivatives
US4462986A (en) * 1982-11-04 1984-07-31 Ens Bio Logicals, Inc. Synergistic anti-herpes compositions
US4814335A (en) * 1982-12-30 1989-03-21 Biomeasure, Incorporated Antiviral compounds
US4461757A (en) * 1983-02-23 1984-07-24 Ens Bio Logicals Inc. Dimethylaminomethylenated anti-herpes compounds
US5047533A (en) * 1983-05-24 1991-09-10 Sri International Acyclic purine phosphonate nucleotide analogs
US4880820A (en) * 1983-06-24 1989-11-14 Merck & Co., Inc. Guanine derivatives
GB8320308D0 (en) * 1983-07-28 1983-09-01 Wellcome Found Antiviral combinations
US4897479A (en) * 1983-09-30 1990-01-30 Merck & Co., Inc. Arylsulfonyloxy purine intermediates
EP0138683A3 (fr) * 1983-09-30 1988-01-20 Merck & Co. Inc. Dérivés de purine, leur application dans des compositions anti-virales
IE842642L (en) * 1983-10-31 1985-04-30 Harvard College Purine Derivatives
US4806642A (en) * 1984-10-05 1989-02-21 Warner-Lambert Company Purine derivatives
IL73682A (en) * 1983-12-20 1991-08-16 Medivir Ab Antiviral pharmaceutical compositions containing 9-hydroxy aliphatic derivatives of guanine,some new such derivatives and process for their preparation
US4621140A (en) * 1984-02-23 1986-11-04 Syntex (U.S.A.) Inc. Process for preparing 2,6-substituted-9-(1,3-dihydroxy-2-propoxymethyl)-purines and certain derivatives
US4579849A (en) * 1984-04-06 1986-04-01 Merck & Co., Inc. N-alkylguanine acyclonucleosides as antiviral agents
WO1986000901A1 (fr) * 1984-07-20 1986-02-13 Gauntt Charles O Compose immunoregulateur et anti-viral
NO172183C (no) * 1984-12-12 1993-06-16 Syntex Inc Fremgangsmaate for fremstilling av derivater av 9-(1,3-dikydroksy-2-propoksymetyl)-guanin
SE8406538D0 (sv) 1984-12-21 1984-12-21 Astra Laekemedel Ab Novel derivatives of purine
US4642346A (en) * 1985-06-24 1987-02-10 Syntex (U.S.A.) Inc. Anhydrous crystalline 9-(1,3-dihydroxy-2-propoxymethyl)guanine
US4863927A (en) * 1987-05-11 1989-09-05 Merck & Co., Inc. 1-(2-hydroxymethyl)cycloalkylmethyl)-5-substituted uracils
CA2005815C (fr) * 1988-12-19 1999-08-03 Wellcome Foundation Limited (The) Derives antiviraux de nucleoside acyclique
US5068119A (en) * 1990-09-28 1991-11-26 Nabisco Brands, Inc. Acid-hydrolyzable ester derivatives as low calorie fat mimetics
GB2260319B (en) 1991-10-07 1995-12-06 Norsk Hydro As Acyl derivatives of nucleosides and nucleoside analogues having anti-viral activity
CN1040759C (zh) * 1993-06-23 1998-11-18 默里尔药物公司 作为抗病毒剂和抗肿瘤剂的碳-无环核苷衍生物
US5543414A (en) * 1994-07-28 1996-08-06 Syntex (Usa) Inc. Achiral amino acid acyl esters of ganciclovir and its derivatives
US6083953A (en) * 1994-07-28 2000-07-04 Syntex (U.S.A.) Inc. 2- (2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3- propanediol derivative
US5565565A (en) * 1994-08-04 1996-10-15 Syntex (U.S.A.) Inc. Preparation of N-9 substituted guanine compounds
US5627185A (en) * 1994-11-23 1997-05-06 Gosselin; Gilles Acyclovir derivatives as antiviral agents
US5840763A (en) * 1994-12-12 1998-11-24 Smithkline Beecham Plc Treatment of a latent infection of herpes viruses
DE19536164A1 (de) * 1995-09-28 1997-04-03 Boehringer Ingelheim Kg Verbessertes Verfahren zur Herstellung von 9-[(2-Hyroxyethoxy)methyl]guanin (Acyclovir)
US5700936A (en) * 1996-01-26 1997-12-23 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol valinate
US5756736A (en) * 1996-01-26 1998-05-26 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
US5840890A (en) * 1996-01-26 1998-11-24 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
US6040446A (en) 1996-01-26 2000-03-21 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol derivative
IN179493B (fr) * 1996-02-22 1997-10-11 Lupin Laboraties Ltd
EP0806425B1 (fr) * 1996-04-09 2001-08-29 Lupin Laboratories Limited Procédé régiospécifique amélioré pour la synthèse de nucléosides acycliques
US5852208A (en) * 1996-08-30 1998-12-22 Dixie Chemical Company, Inc. Method of producing compounds containing acyloxyalkoxy groups from alcohols
CN1091445C (zh) * 1999-12-29 2002-09-25 湖北省医药工业研究院 抗病毒药物中间体、它们的制备及应用
CA2477088A1 (fr) 2002-02-22 2003-10-02 New River Pharmaceuticals Inc. Systemes de distribution d'agents actifs et methodes de protection et d'administration d'agents actifs
WO2004037263A1 (fr) * 2002-10-22 2004-05-06 Ranbaxy Laboratories Limited Compositions pharmaceutiques de ganciclovir
US20060142574A1 (en) * 2002-10-31 2006-06-29 Babu Jayachandra S Process for the preparation of ganciclovir
WO2004048380A1 (fr) * 2002-11-22 2004-06-10 Ranbaxy Laboratories Limited Procede de synthese de ganciclovir
JP4996241B2 (ja) 2003-01-14 2012-08-08 ギリアード サイエンシーズ, インコーポレイテッド 組み合わせ抗ウイルス治療のための組成物および方法
ITMI20031202A1 (it) * 2003-06-13 2004-12-14 Lyogen Ltd Forma di cristallina del ganciclovir
WO2005021549A1 (fr) * 2003-08-28 2005-03-10 Ranbaxy Laboratories Limited Chlorhydrate de valganciclovir amorphe
JP4746866B2 (ja) * 2004-11-19 2011-08-10 Tcm株式会社 キャリッジ用ガタ抑制装置
TWI375560B (en) * 2005-06-13 2012-11-01 Gilead Sciences Inc Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same
TWI471145B (zh) 2005-06-13 2015-02-01 Bristol Myers Squibb & Gilead Sciences Llc 單一式藥學劑量型
EP2085397A1 (fr) 2008-01-21 2009-08-05 Esteve Quimica, S.A. Forme cristalline d'abacavir
WO2009120358A1 (fr) * 2008-03-27 2009-10-01 Nektar Therapeutics Conjugués oligomère-base azotée
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
US8716263B2 (en) 2008-12-23 2014-05-06 Gilead Pharmasset Llc Synthesis of purine nucleosides
PA8855601A1 (es) 2008-12-23 2010-07-27 Forformidatos de nucleósidos
US8551973B2 (en) * 2008-12-23 2013-10-08 Gilead Pharmasset Llc Nucleoside analogs
CN101851239B (zh) * 2009-04-03 2012-11-28 上海益威实业有限公司 一种更昔洛韦的回收方法
WO2011123668A2 (fr) 2010-03-31 2011-10-06 Pharmasset, Inc. Synthèse stéréosélective d'agents actifs contenant du phosphore
WO2012154698A2 (fr) * 2011-05-06 2012-11-15 Mckenna Charles E Procédé d'amélioration de l'activité antivirale de médicaments analogues de nucléotides
CN102627643B (zh) * 2012-04-10 2014-01-08 常州康丽制药有限公司 更昔洛韦的精制方法
CA2889903C (fr) 2012-10-29 2021-03-09 Manjinder Singh Phull Analogues de phosphonate antiviraux et leur procede de preparation
EP2914588B1 (fr) * 2012-11-03 2016-09-14 Boehringer Ingelheim International GmbH Inhibiteurs du cytomégalovirus
CN103059023B (zh) * 2012-12-31 2015-09-30 浙江车头制药股份有限公司 一种制备更昔洛韦晶型ⅱ的方法
US9486530B1 (en) 2013-08-30 2016-11-08 Exela Pharma Sciences, LLC Ganciclovir compositions and related methods
US20230218644A1 (en) 2020-04-16 2023-07-13 Som Innovation Biotech, S.A. Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus
CN113476413B (zh) * 2021-08-09 2022-06-28 海南海灵化学制药有限公司 一种注射用更昔洛韦钠冻干粉的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1523865A (en) * 1974-09-02 1978-09-06 Wellcome Found Purine compunds and salts thereof
US4199574A (en) * 1974-09-02 1980-04-22 Burroughs Wellcome Co. Methods and compositions for treating viral infections and guanine acyclic nucleosides
US4060616A (en) * 1976-03-01 1977-11-29 Burroughs Wellcome Co. Purine derivatives with repeating unit
US4221910A (en) * 1978-09-15 1980-09-09 Newport Pharmaceuticals International, Inc. 9-(Hydroxy alkyl)purines
US4347360A (en) * 1980-09-16 1982-08-31 Ens Bio Logicals Inc. Ring open nucleoside analogues
AU7938482A (en) * 1980-12-22 1982-07-20 Astra Lakemedel Aktiebolag Novel derivatives of guanine
IE54148B1 (en) * 1981-08-11 1989-07-05 Wellcome Found Antiviral compounds

Also Published As

Publication number Publication date
DD213218A5 (de) 1984-09-05
GR76459B (fr) 1984-08-10
US4355032B2 (en) 1990-10-30
DK227782A (da) 1982-11-22
SU1176841A3 (ru) 1985-08-30
DD203052A5 (de) 1983-10-12
IE53731B1 (en) 1989-02-01
FI73682B (fi) 1987-07-31
ES8500276A1 (es) 1984-11-01
ES524899A0 (es) 1985-09-16
ZA823532B (en) 1983-03-30
RO84860B (ro) 1984-10-30
DK150304C (da) 1988-01-04
DK149001C (da) 1988-11-28
NZ200691A (en) 1986-11-12
PL136579B1 (en) 1986-02-28
LU88334I2 (fr) 1994-09-09
CS235043B2 (en) 1985-04-16
DK150304B (da) 1987-02-02
EP0066208B1 (fr) 1985-10-02
FI73682C (fi) 1987-11-09
DK504183A (da) 1983-11-03
NO161740C (no) 1989-09-20
IL65836A (en) 1991-04-15
PL136332B1 (en) 1986-02-28
SG81687G (en) 1989-07-07
US4355032A (en) 1982-10-19
ES529384A0 (es) 1987-01-01
PL136004B1 (en) 1986-01-31
PT74934A (en) 1982-06-01
IN156469B (fr) 1985-08-10
RO87387A (fr) 1985-08-31
KR890004663B1 (ko) 1989-11-24
NO161740B (no) 1989-06-12
NL930139I1 (nl) 1993-11-01
ES533821A0 (es) 1985-06-16
US4355032B1 (fr) 1983-06-14
JPH0529399B2 (fr) 1993-04-30
PL246770A1 (en) 1984-08-27
JPH046195B2 (fr) 1992-02-05
ES520849A0 (es) 1984-11-01
ES524900A0 (es) 1985-11-16
CS235044B2 (en) 1985-04-16
ES8507549A1 (es) 1985-09-16
HK67088A (en) 1988-09-02
PL236521A1 (en) 1984-01-02
ES8701496A1 (es) 1987-01-01
BR8202931A (pt) 1983-05-03
CA1305141C (fr) 1992-07-14
CA1305140C (fr) 1992-07-14
RO87387B (ro) 1985-08-31
CA1305139C (fr) 1992-07-14
JPH04217983A (ja) 1992-08-07
FI821794A0 (fi) 1982-05-20
IE821210L (en) 1982-11-21
NO1994005I1 (no) 1994-07-29
PT74934B (en) 1984-05-08
JPS57203086A (en) 1982-12-13
ATE15899T1 (de) 1985-10-15
ES8601204A1 (es) 1985-11-16
ES8404355A1 (es) 1984-05-01
AU8389282A (en) 1982-11-25
KR830010112A (ko) 1983-12-26
CS235042B2 (en) 1985-04-16
ES8505681A1 (es) 1985-06-16
DK504183D0 (da) 1983-11-03
NL930139I2 (nl) 1997-07-01
CS235018B2 (en) 1985-04-16
HU186514B (en) 1985-08-28
PL242100A1 (en) 1984-04-24
PL242101A1 (en) 1984-07-16
NL930022I1 (nl) 1993-05-03
ES512414A0 (es) 1984-05-01
IL65836A0 (en) 1982-08-31
RO84860A (fr) 1984-09-29
AU572086B2 (en) 1988-05-05
HU188000B (en) 1986-03-28
AR244227A1 (es) 1993-10-29
NO821676L (no) 1982-11-22
DE3266644D1 (en) 1985-11-07
ES529383A0 (es) 1986-05-16
EP0066208A1 (fr) 1982-12-08
DK149001B (da) 1985-12-16
ES8606869A1 (es) 1986-05-16
PL136637B1 (en) 1986-03-31
PH17975A (en) 1985-02-22

Similar Documents

Publication Publication Date Title
MY8700793A (en) 9-(1,3-dihydroxy-2-propoxymethyl)-guanine as anti viral agent
AU1261488A (en) Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) purines as antiviral agent
JPS57194106A (en) Tire
IL66676A (en) Tire
GR77865B (fr)
JPS57201705A (en) Tire
FR2532856B1 (fr)
DE3272079D1 (en) Tripod-type undercarriage
GB8324194D0 (en) Caster
FR2525378B1 (fr)
FR2523576B1 (fr)
IL61535A0 (en) 1-oxo-1h-thiazolo(3,2-a)pyrimidine-2-carboxamides
FR2522991B1 (fr)
FR2521037B1 (fr)
GR77488B (fr)
FR2531499B3 (fr)
ZA83626B (en) Substituted 9-(1 or 3-monoacyloxy or 1, 3-diacyloxy-2-propoxy-methyl purines as antiviral agent
GB8301394D0 (en) Wheel brace
FR2526705B1 (fr)
GB8312333D0 (en) Wheels
IE820064L (en) 2-oxa-bicyclo(3,3,0)octanes
AU87393S (en) Sulky wheel
AU2079183A (en) Dolly
IE822958L (en) Azabicyclo derivatives.
GR69500B (fr)